GlaxoSmithKline on Monday agreed to pay $5.1 billion for Tesaro, becoming the latest firm to bet on a new type of cancer drug that has shown promise treating multiple tumor types but has yet to become a blockbuster seller. GSK said it will pay $75 per share in cash for Waltham, MA-basd Tesaro, the owner of a cancer drug called niraparib. … Read more at Xconomy.



Three Local Colleges On List of Most Underrated Schools in the Country

CollegeVine, a Cambridge-based college guidance company, recently examined the “most underrated” colleges in the United States, by comparing their cost of attendance and generosity of financial aid with “qualitative data” on students’ career outcomes. … Both Babson College and Wellesley College, located only two miles away from each other in the affluent suburb, came in ninth and 10th, respectively, in CollegeVine’s ranking. … Read more at



What Do Opportunity Zones Mean for Boston Real Estate?

Massachusetts Gov. Charlie Baker’s administration designated 138 areas across Massachusetts in April as opportunity zones, a tax incentive created by the 2017 tax reform law. Aimed at spurring development in low-income neighborhoods, the plan gives deferment, and even exemption, of capital gains taxes to those investing in businesses and real estate, depending on how long the investor holds onto the asset. … Read more at BisNow.



RoadBotics Closes $3.9 Million Seed Round

RoadBotics, a startup that spun out of Carnegie Mellon University Robotics Institute in 2016, raised a seed round of $3.9 million from Boston-based Hyperplane Ventures. As part of the round, the company plans to build a sales presence in Boston to serve its dozen customers in the New England region. … Read more at American Innovation.